Crossmark

<scp>PM2</scp> .5 promotes lung cancer progression through activation of the <scp>AhR‐TMPRSS2‐IL18</scp> pathway

Crossref DOI link: https://doi.org/10.15252/emmm.202217014

Published Online: 2023-03-28

Published Print: 2023-06-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Wang, Tong‐Hong https://orcid.org/0000-0001-9248-9031
Huang, Kuo‐Yen https://orcid.org/0000-0002-5542-3567
Chen, Chin‐Chuan

Chang, Ya‐Hsuan

Chen, Hsuan‐Yu

Hsueh, Chuen

Liu, Yi‐Tsen

Yang, Shuenn‐Chen

Yang, Pan‐Chyr https://orcid.org/0000-0001-6330-6048
Chen, Chi‐Yuan https://orcid.org/0000-0003-4995-297X
Funding

Funding for this research was provided by:

Chang Gung Memorial Hospital (CMRPF1M0051)

Chang Gung Memorial Hospital (CMRPF1M0052)
License Information

Version of Record valid from 2023-03-28
More Information

Publication History

Received: 2022-10-10

Accepted: 2023-03-14

Published: 2023-03-28